TREND and COVID 19: An Open Letter in Response to the Pandemic
For the use of screen readers, we have pasted the letter in plain text below. Like most businesses around the world, TREND has been impacted
For the use of screen readers, we have pasted the letter in plain text below. Like most businesses around the world, TREND has been impacted
There has always been a huge amount of misinformation surrounding health. From the ancient notion that many diseases were caused by “bad blood,” to traveling
Philadelphia, Pa — TREND Community, a digital health company that uses AI technology to advance understanding of diseases from patient and caregiver conversations on social
To use a screen reader, the text is copied below: 2019 Annual Letter Dear Community, 2019 was a year of discovery and progress for TREND.
Rare diseases are not all that rare—it’s a paradox we hear all the time. With more than 7,000 known examples, and upwards of 25 million
Patient-centricity is bound to be one of the most ubiquitous industry buzzwords of 2020. Every party involved in healthcare has a vested interest in more
TREND is very excited to have contributed to Kiniksa’s application for Breakthrough Therapy designation, which was awarded by the FDA for rilonacept for the treatment
It is easy to regard an individual rare disease as an affliction that only impacts a small number of people, but rare diseases affect hundreds
To continue bridging the gap between patient communities and the industries that serve them, TREND began a search for a writer to help them manage
Yesterday, Harmony Biosciences announced FDA Approval Of WAKIX (pitolisant), A First-In-Class Medication For The Treatment Of Excessive Daytime Sleepiness In Adult Patients With Narcolepsy. Read